The document summarizes a research project that aims to investigate the influence of resveratrol, epsilon-viniferin, piceatannol and xanthohumol on neurodegenerative processes and their role in regulating sirtuin 1 (SIRT1) activity. The methodology involves building a cellular model of Alzheimer's disease and determining the effects of the polyphenols on SIRT1 catalytic activity, amyloid β levels, and other markers. The research is expected to provide useful insights into the protective mechanisms of the compounds and potentially lead to applications in therapies by optimizing SIRT1 activity.